NBRV - Nabriva names Daniel Dolan CFO

Nabriva Therapeutics (NBRV) names Daniel Dolan as Chief Financial Officer, effective close of business March 12, 2021.Dolan will replace current CFO Gary Sender, who is retiring from Nabriva. Sender will serve as a consultant for Nabriva at least through the remainder of 2021 to support Dolan’s transition into the role.Dolan has more than 20 years of global, corporate finance and executive management experience, and most recently, he served as principal financial officer of Radius Health.Nabriva shares were trading up marginally during premarket.

For further details see:

Nabriva names Daniel Dolan CFO